SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for Melanoma, Cutaneous Malignant
40 locations incl. Phoenix
Sponsor: Immatics US, Inc.
Sex: All·Age: 18+
Code: NCT06743126·Phase 3·Recruiting